Post by Hologic, Inc.

Exciting news! Our diagnostics solution, Aptima® HPV Assay, received an expanded CE-IVDR marking in the EU and the UK for self-collected vaginal samples using the Aptima Multitest Specimen Collection Kit. Women will be able to self-collect samples in a healthcare setting for cervical cancer screening. This offers an alternative screening method and has the potential to improve HPV screening participation rates in under-screened populations. Read the full announcement: https://ow.ly/e9sY50Znjbe